便潜血検査市場規模、シェア、成長分析：検査タイプ別、エンドユーザー別、地域別 - 産業予測、2025年～2032年

便潜血検査の世界市場規模は、2023年に1,925億7,000万米ドルと評価され、2024年の2,068億2,000万米ドルから2032年には3,661億2,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.4％で成長する見通しです。

世界の便潜血検査市場は、便サンプル中の隠れた血液を検出するために極めて重要であり、早期結腸がん診断や様々な消化器疾患のモニタリングのための重要な方法として役立っています。大腸がん罹患率の増加、検診に対する政府の支援策、医療インフラの改善、革新的な検査技術の採用などが市場成長の原動力となっています。しかし、意識のギャップと高コストが拡大への課題となっています。機会としては、消費者直接検査オプションの台頭や、家庭用免疫学的検査機器がオンラインで入手可能になったことが挙げられます。同市場は、グアイアックFOB検査や免疫FOB検査など製品タイプ別に分類され、北米や欧州を中心とする各地域の病院や検査機関など多様なエンドユーザーにサービスを提供しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

便潜血検査市場規模：検査タイプ別& CAGR（2025-2032）

• 市場概要
• グアイアックFOB便検査
• 免疫FOB凝集試験
• ラテラルフロー免疫FOB検査
• 免疫FOB ELISA検査

便潜血検査市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 大腸がん
• 消化管出血
• 貧血
• その他

便潜血検査市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 診断センター
• その他

便潜血検査市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Quidel Corporation（United States）
• Wondfo（China）
• Siemens Healthineers（Germany）
• Eiken Chemical Co., Ltd.（Japan）
• Biohit Oyj（Finland）
• Becton, Dickinson and Company（BD）（United States）
• Trinity Biotech（Ireland）
• Meridian Bioscience（United States）
• Beckman Coulter（United States）
• Inova Diagnostics（United States）
• Bio-Rad Laboratories（United States）
• Abbott Laboratories（United States）
• Roche Diagnostics（Switzerland）
• Sysmex Corporation（Japan）
• US Diagnostics（United States）
• Sekisui Diagnostics（United States）
• FUJIFILM Wako Pure Chemical Corporation（Japan）
• Helena Laboratories（United States）
• Exact Sciences Corp.（United States）

結論と推奨事項

Global Fecal Occult Testing Market size was valued at USD 192.57 billion in 2023 and is poised to grow from USD 206.82 billion in 2024 to USD 366.12 billion by 2032, growing at a CAGR of 7.4% during the forecast period (2025-2032).

The global fecal occult testing market is crucial for detecting hidden blood in stool samples, serving as a key method for early colon cancer diagnosis and monitoring various gastrointestinal conditions. Market growth is fueled by increasing rates of colorectal cancer, supportive government initiatives for screening, improvements in medical infrastructure, and the adoption of innovative testing techniques. However, awareness gaps and high costs pose challenges to expansion. Opportunities arise from the rise of direct-to-consumer testing options and the availability of at-home immunological test devices online. The market is categorized by product types, including guaiac FOB tests and immuno-FOB tests, and serves diverse end users such as hospitals and laboratories across regions, notably North America and Europe.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Fecal Occult Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Fecal Occult Testing Market Segments Analysis

Global Fecal Occult Testing Market is segmented by Test Type, Application, End-use and Region. Based on Test Type, the market is segmented into Guaiac FOB stool test, Immuno-FOB agglutination test, Lateral flow immuno-FOB test and Immuno-FOB ELISA test. Based on Application, the market is segmented into Colorectal Cancer, Gastrointestinal Bleeding, Anemia and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Fecal Occult Testing Market

The Global Fecal Occult Testing market is significantly influenced by rising public awareness campaigns and healthcare initiatives that emphasize the necessity of colorectal cancer screening. These efforts have heightened understanding among both the general public and healthcare professionals regarding the critical role of regular screening in early detection. Additionally, government-supported screening programs and established guidelines advocating for routine fecal occult blood testing in specific age demographics are further propelling the demand for these essential tests. As awareness continues to grow, more individuals are likely to participate in screening, thereby driving market expansion and fostering early diagnosis and treatment of colorectal cancer.

Restraints in the Global Fecal Occult Testing Market

The global fecal occult testing market faces significant restraints due to the potential for false positive and false negative results, which can lead to diagnostic inaccuracies that affect patient care. False positives may result in unnecessary follow-up tests or procedures, causing patient anxiety and increased healthcare costs. On the other hand, false negatives may lead to overlooked diagnoses, delaying vital treatments. It is essential to address these limitations regarding the sensitivity and specificity of fecal occult blood tests to ensure the preservation of trust in their diagnostic capacity, ultimately impacting the market's growth and acceptance among healthcare practitioners and patients alike.

Market Trends of the Global Fecal Occult Testing Market

The global fecal occult testing market is witnessing a significant trend towards point-of-care testing, driven by the demand for rapid and convenient diagnostic solutions. These tests, optimized for primary care settings and community health clinics, particularly enhance accessibility in remote and underserved areas lacking laboratory facilities. The focus is on developing user-friendly, cost-effective point-of-care tests that enable broader screening opportunities and improve early detection rates of gastrointestinal diseases. This trend is expected to expand the market further, as healthcare providers increasingly embrace technologies that facilitate timely patient care and enhance health outcomes in resource-constrained environments.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Fecal Occult Testing Market Size by Test Type & CAGR (2025-2032)

• Market Overview
• Guaiac FOB stool test
• Immuno-FOB agglutination test
• Lateral flow immuno-FOB test
• Immuno-FOB ELISA test

Global Fecal Occult Testing Market Size by Application & CAGR (2025-2032)

• Market Overview
• Colorectal Cancer
• Gastrointestinal Bleeding
• Anemia
• Others

Global Fecal Occult Testing Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic centers
• Others

Global Fecal Occult Testing Market Size & CAGR (2025-2032)

• North America (Test Type, Application, End-use)
  • US
  • Canada
• Europe (Test Type, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Quidel Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wondfo (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eiken Chemical Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biohit Oyj (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inova Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• US Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM Wako Pure Chemical Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Helena Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exact Sciences Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations